Literature DB >> 9867776

Fatal hepatotoxicity associated with troglitazone.

A Vella, P C de Groen, S F Dinneen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9867776     DOI: 10.7326/0003-4819-129-12-199812150-00032

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  8 in total

1.  Severe but reversible hepatitis induced by troglitazone.

Authors:  T Schiano; K Dolehide; J Hart; A L Baker
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

Review 2.  The glitazones: proceed with caution.

Authors:  D Krische
Journal:  West J Med       Date:  2000-07

Review 3.  Modern pharmacotherapies for type 2 diabetes mellitus.

Authors:  S H Hsia
Journal:  J Natl Med Assoc       Date:  2001-09       Impact factor: 1.798

Review 4.  Important elements for the diagnosis of drug-induced liver injury.

Authors:  Vijay K Agarwal; John G McHutchison; Jay H Hoofnagle
Journal:  Clin Gastroenterol Hepatol       Date:  2010-02-17       Impact factor: 11.382

5.  Current and novel therapies for the treatment of nonalcoholic steatohepatitis.

Authors:  David van der Poorten; Jacob George
Journal:  Hepatol Int       Date:  2007-07-26       Impact factor: 6.047

Review 6.  Hepatotoxicity with thiazolidinediones: is it a class effect?

Authors:  A J Scheen
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 7.  Troglitazone: a review of its use in the management of type 2 diabetes mellitus.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1999-03       Impact factor: 9.546

8.  Design, synthesis, biological activity and molecular dynamics studies of specific protein tyrosine phosphatase 1B inhibitors over SHP-2.

Authors:  Su-Xia Sun; Xiao-Bo Li; Wen-Bo Liu; Ying Ma; Run-Ling Wang; Xian-Chao Cheng; Shu-Qing Wang; Wei Liu
Journal:  Int J Mol Sci       Date:  2013-06-17       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.